Investor's Business Daily on MSN
ANI Pharmaceuticals sees relative strength rating improve to 73
A Relative Strength Rating upgrade for ANI Pharmaceuticals shows improving technical performance. Will it continue?
Amid the dozens of publicly traded firms in Minnesota, Baudette-based ANI Pharmaceuticals Inc. often flies under the radar. The pharmaceutical company about five hours north of Minneapolis has grown ...
Investor's Business Daily on MSN
ANI Pharmaceuticals receives IBD stock rating upgrade
ANI Pharmaceuticals ANIP saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 93 the day before. Please ...
Levator ani syndrome is a type of pelvic floor dysfunction that happens when the muscles are too tight. Treatment can involve exercises, therapy, and pain relievers. Levator ani syndrome is a type of ...
BAUDETTE, Minn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the fourth quarter and ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, and contract manufacturing. Despite cash burn concerns, ANI's revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback